Full Text View
Tabular View
No Study Results Posted
Related Studies
Helicobacter Pylori Eradication Rate According to Clarithromycin Resistance
This study is currently recruiting participants.
Verified May 2012 by The Catholic University of Korea
Study NCT01453036   Information provided by The Catholic University of Korea

First Received on September 29, 2011.   Last Updated on May 7, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Peptic Ulcer
Helicobacter Pylori Infection
Additional conditions recognized in this trial
Helicobacter Infections
Ulcer
More general conditions related to this trial
Bacterial Infections
Digestive System Diseases
Duodenal Diseases
Gastrointestinal Diseases
Gram-Negative Bacterial Infections
Intestinal Diseases
Pathologic Processes
Stomach Diseases
Additional drug interventions recognized in this trial
Clarithromycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Jin Il Kim
Korean College of Helicobacter and Upper Gastrointestinal Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services